NOX1 supports the metabolic remodeling of HepG2 cells

Katharina Bertram1, Cristina-Maria Valcu1, Michael Weitnauer1

  • 1Experimental and Molecular Paediatric Cardiology, German Heart Centre Munich at the Technical University Munich, Lazarettstr. 36, Munich, Germany.

Plos One
|March 26, 2015
PubMed

Insights

NADPH oxidase 1 (NOX1) fuels cancer growth by altering cell metabolism. Depleting NOX1 in liver cancer cells revealed its role in regulating essential building blocks for proliferation, suggesting NOX1 as a therapeutic target.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • NADPH oxidases (NOX) generate reactive oxygen species (ROS) crucial for cellular signaling.
  • NOX1 overexpression is linked to cancer progression, but its specific roles remain unclear.

Purpose of the Study:

  • To investigate the impact of NOX1 on protein expression and cellular metabolism in hepatoblastoma.
  • To identify NOX1-dependent pathways involved in tumor cell metabolic reprogramming.

Main Methods:

  • Engineered NOX1-depleted HepG2 hepatoblastoma cells.
  • Utilized differential display 2D gel electrophoresis (2DE) for proteomic analysis.

Main Results:

  • Identified 17 dysregulated protein functions in NOX1-depleted cells.
  • Linked NOX1 to the Warburg effect, impacting glucose/glutamine metabolism and biosynthesis.
  • Demonstrated NOX1's role in metabolic remodeling for sustained proliferation in liver cancer cells.

Conclusions:

  • NOX1 significantly contributes to the metabolic reprogramming of hepatoblastoma cells.
  • NOX1 supports the production of building blocks necessary for high proliferative rates in cancer.
  • NOX1 emerges as a potential therapeutic target for liver cancer treatment.